Carcinoma of the OvaryHEINTZ, A. P. M; ODICINO, F; MAISONNEUVE, P et al.International journal of gynecology & obstetrics. Supplement. 2006, Vol 95, Num 1, issn 0924-8447, S161-S192Article

Total inhibin is a potential serum marker for epithelial ovarian cancerTSIGKOU, Anastasia; MARRELLI, Daniele; REIS, Fernando M et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 7, pp 2526-2531, issn 0021-972X, 6 p.Article

Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancerPOPADIUK, Cathy M; JIEYING XIONG; WELLS, Malcolm G et al.Clinical cancer research. 2006, Vol 12, Num 7, pp 2216-2223, issn 1078-0432, 8 p., 1Article

Meningeal metastases from ovarian carcinomaMUKHOPADHYAY, Surabhi; MUKHOPADHYAY, Sanjay; EL-ZAMMAR, Ola et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 1010-1011, issn 0732-183X, 2 p.Article

Long-term survival of patients with apparent early-stage (FIGO I-II) epithelial ovarian cancer : A population-based studyPETIGNAT, Patrick; DE WECK, Daniel; GOFFIN, Frederic et al.Gynecologic and obstetric investigation. 2007, Vol 63, Num 3, pp 132-136, issn 0378-7346, 5 p.Article

Tight junction formation in epithelial ovarian adenocarcinomaYIHONG ZHU; SUNDFELDT, Karin.Acta obstetricia et gynecologica Scandinavica. 2007, Vol 86, Num 8, pp 1011-1019, issn 0001-6349, 9 p.Article

Hepatoid carcinoma of the ovary and managementLAZARO, Jesus; RUBIO, Dolores; REPOLLES, Manuel et al.Acta obstetricia et gynecologica Scandinavica. 2007, Vol 86, Num 4, pp 498-499, issn 0001-6349, 2 p.Article

Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: How lucky are the lucky ones?LIAVAAG, Astrid H; DØRUM, Anne; FOSSA, Sophie D et al.Journal of clinical oncology. 2007, Vol 25, Num 15, pp 2049-2056, issn 0732-183X, 8 p.Article

Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancerGARG, Manoj; CHAURASIYA, Dipak; GUPTA, Anju et al.Clinical cancer research. 2007, Vol 13, Num 5, pp 1421-1428, issn 1078-0432, 8 p.Article

A distinct molecular profile associated with mucinous epithelial ovarian cancerHEINZELMANN-SCHWARZ, V. A; GARDINER-GARDEN, M; FINK, D et al.British journal of cancer. 2006, Vol 94, Num 6, pp 904-913, issn 0007-0920, 10 p.Article

Association of decreased mitochondrial DNA content with ovarian cancer progressionWANG, Y; LIU, V. W. S; XUE, W. C et al.British journal of cancer. 2006, Vol 95, Num 8, pp 1087-1091, issn 0007-0920, 5 p.Article

Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinomaMACOR, Paolo; MEZZANZANICA, Delia; COSSETTI, Chiara et al.Cancer research (Baltimore). 2006, Vol 66, Num 7, pp 3876-3883, issn 0008-5472, 8 p.Article

Diagnosis and management of epithelial ovarian cancerBHOOLA, Snehal; HOSKINS, William J.Obstetrics and gynecology (New York. 1953). 2006, Vol 107, Num 6, pp 1399-1410, issn 0029-7844, 12 p.Article

Differential gene expression identifies subgroups of ovarian carcinomaSKUBITZ, Amy P. N; PAMBUCCIAN, Stefan E; ARGENTA, Peter A et al.Translational research. 2006, Vol 148, Num 5, pp 223-248, 26 p.Article

Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinomaYEN, M. Jim; HSU, Chih-Yi; MAO, Tsui-Lien et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 827-831, issn 1078-0432, 5 p., 1Article

Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cellsSYMOWICZ, Jaime; ADLEY, Brian P; WOO, Michelle M. M et al.Cancer research (Baltimore). 2005, Vol 65, Num 6, pp 2234-2242, issn 0008-5472, 9 p.Article

Ovarian carcinomas : CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cellsGERY, Sigal; DONG XIE; KOEFFLER, H. Phillip et al.Clinical cancer research. 2005, Vol 11, Num 20, pp 7243-7254, issn 1078-0432, 12 p.Article

Role of chemotherapy in the management of epithelial ovarian cancerREEDS, Nicholas S; SADOZYE, Azmat H.Expert review of anticancer therapy. 2005, Vol 5, Num 1, pp 139-147, issn 1473-7140, 9 p.Article

The Notch pathway in ovarian carcinomas and adenomasHOPFER, O; ZWAHLEN, D; FEY, M. F et al.British journal of cancer. 2005, Vol 93, Num 6, pp 709-718, issn 0007-0920, 10 p.Article

Phosphatidylinostol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinomaLIMIN HU; HOFMANN, Judith; JAFFE, Robert B et al.Clinical cancer research. 2005, Vol 11, Num 22, pp 8208-8212, issn 1078-0432, 5 p.Article

Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancerPSYRRI, Amanda; BAMIAS, Aris; DIMOPOULOS, Meletios A et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8384-8390, issn 1078-0432, 7 p.Article

Advances in the early detection of ovarian carcinomaGARNER, Elizabeth I. O.Journal of reproductive medicine. 2005, Vol 50, Num 6, pp 447-453, issn 0024-7758, 7 p.Conference Paper

Clinical trials in ovarian carcinoma : requirements for standard approaches and regimensTHIGPEN, T; STUART, G; MEIER, W et al.Annals of oncology. 2005, Vol 16, pp viii13-viii19, issn 0923-7534, SUP8Conference Paper

Loss of β-catenin is associated with poor survival in ovarian carcinomasFALEIRO-RODRIGUES, Cristina; MACEDO-PINTO, Isabel; PEREIRA, Deolinda et al.International journal of gynecological pathology. 2004, Vol 23, Num 4, pp 337-346, issn 0277-1691, 10 p.Article

CT features of serous surface papillary carcinoma of the ovaryHYE JIN KIM; JEONG KON KIM; CHO, Kyoung-Sik et al.American journal of roentgenology (1976). 2004, Vol 183, Num 6, pp 1721-1724, issn 0361-803X, 4 p.Article